Intelligent Bio Solutions, Inc. (INBS)
2.51
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
2.33
-0.18
(-7.17%)
After-Hours: 20:00
Intelligent Bio Solutions Total Liabilities (Quarterly) : 6.991M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.991M |
| March 31, 2026 | 6.112M |
| December 31, 2025 | 6.763M |
| September 30, 2025 | 6.611M |
| June 30, 2025 | 5.451M |
| March 31, 2025 | 4.641M |
| December 31, 2024 | 4.481M |
| September 30, 2024 | 5.777M |
| June 30, 2024 | 5.596M |
| March 31, 2024 | 6.041M |
| December 31, 2023 | 5.673M |
| September 30, 2023 | 7.464M |
| June 30, 2023 | 6.668M |
| March 31, 2023 | 4.742M |
| December 31, 2022 | 6.227M |
| September 30, 2022 | 2.378M |
| June 30, 2022 | 4.714M |
| Date | Value |
|---|---|
| March 31, 2022 | 4.469M |
| December 31, 2021 | 4.040M |
| September 30, 2021 | 2.863M |
| June 30, 2021 | 3.704M |
| March 31, 2021 | 1.577M |
| December 31, 2020 | 1.184M |
| September 30, 2020 | 5.954M |
| June 30, 2020 | 7.690M |
| March 31, 2020 | 7.820M |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | 6.305M |
| March 31, 2019 | 6.017M |
| December 31, 2018 | 5.560M |
| September 30, 2018 | |
| June 30, 2018 | 5.560M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Sanara MedTech, Inc. | 61.21M |
| Anteris Technologies Global Corp. | 20.84M |
| 20/20 Biolabs, Inc. | 2.964M |
| Quest Diagnostics, Inc. | 9.04B |
| Labcorp Holdings, Inc. | 9.909B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.28M |
| Shareholders Equity (Quarterly) | 5.511M |
| Debt to Equity Ratio | 0.3301 |
| Current Ratio | 1.440 |
| Net Debt Paydown Yield | -3.92% |